Advertisement
Loading...

BillionToOne, Inc.

BLLN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$82.63
$-5.31(-6.04%)
U.S. Market opens in 37h 19m

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.8B
P/E Ratio151.26
EPS (TTM)$0.52
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$80.67
3 Months$47.78
1 Year Target$31.99

BLLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BillionToOne, Inc. (BLLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 151.26 and a market capitalization of 3.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.04%
5-Day Change
-8.19%
1-Month Change
2.51%
3-Month Change
-6.75%
6-Month Change
-8.19%
Year-to-Date (YTD) Change
0.97%
1-Year Change
-24.15%
3-Year Change
-24.15%
5-Year Change
-24.15%
All-Time (Max) Change
-24.15%

Contact Information

https://www.billiontoone.com
(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

620 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions